• About Us
    • Company Overview
    • Our History
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Our Advisors
  • Therapeutic Areas
    • COVID-19 and CVD
    • Acute Myocarditis
    • Heart Failure
  • Research
    • R&D Partners
    • Our Science
    • Resources
  • Pipeline
  • CardiolRX™
  • Investors
    • Events & Presentations
    • Press Releases
    • Analyst Coverage
    • Stock Information
    • Filings & Financials
    • Corporate Governance
    • Contact Us
  • Events & Presentations
  • Press Releases
  • Analyst Coverage
  • Stock Information
  • Filings & Financials
  • Corporate Governance
  • Investor Relations Contact
Investors

Press Releases

Press Release

David Elsley Files Early Warning Report for Cardiol Therapeutics

June 25, 2020

Press Release

Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option

June 04, 2020

Press Release

Cardiol Therapeutics Reports 2020 AGM Results

June 02, 2020

Press Release

Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4:30 p.m. EDT

May 29, 2020

Press Release

Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering

May 14, 2020

Press Release

Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering

May 13, 2020

Press Release

Cardiol Therapeutics Files International Patent Application Covering the Use of Cannabidiol (CBD) to Improve the Outcome of Patients with COVID-19

May 06, 2020

Press Release

Cardiol Therapeutics Announces Study Demonstrating its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart

April 14, 2020

Press Release

Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure

April 01, 2020

Page 5 of 10« First«...34567...10...»Last »
  • About Us
  • Therapeutic Areas
  • Research
  • Pipeline
  • CardiolRX™
  • Investors
  • Contact

TSX:CRDL NASDAQ:CRDL

Sign up to receive the latest news from Cardiol Therapeutics

© 2022 Cardiol Therapeutics Inc. All rights reserved.      Terms of Use      Privacy Policy